^
Association details:
Biomarker:BRAF V600E
Cancer:Melanoma
Drug:SB-590885 (BRAF inhibitor)
Direction:Resistant
Evidence:
Evidence Level:
Resistant: D – Preclinical
New
Title:

Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K

Excerpt:
Chronic treatment of additional BRAFV600E melanoma cell lines with 885 led to the emergence of drug resistance.
DOI:
https://doi.org/10.1016/j.ccr.2010.11.023